Editing AI for Wearable Health Devices (section)

== <span style="color: #FFFFFF;">Understanding</span> ==
Wearable AI sits at the convergence of signal processing, machine learning, and clinical validation. The key challenge: physiological sensors on consumer devices are far lower quality than clinical equipment, and the signal of interest (AFib, hypoglycemia onset) is rare relative to the vast amount of normal, artifact-laden data.

**AFib detection — the gold standard success story**: The Apple Heart Study (400,000 participants) validated Apple Watch's AFib detection algorithm: photoplethysmography-based irregular rhythm detection with 84% PPV for AFib. The FDA cleared this via the De Novo pathway. Subsequent algorithms have improved further. This is the largest digital health study ever conducted and demonstrates what FDA-grade wearable AI validation looks like.

**CGM + AI for diabetes**: Continuous glucose monitors (Dexcom G7, Abbott Libre 3) measure interstitial glucose every 5 minutes. ML algorithms predict hypoglycemia 30-60 minutes ahead, enabling proactive intervention. Closed-loop insulin delivery systems (artificial pancreas: Tandem Control-IQ, Omnipod 5) combine CGM + ML + insulin pump to autonomously regulate blood glucose 24/7. This represents the most advanced real-world implementation of wearable ML in clinical medicine.

**Sleep staging**: Clinical sleep studies (polysomnography) require overnight lab visits. Wrist actigraphy + heart rate from consumer wearables enables home sleep staging. ML models (CNNs on HRV + movement signals) achieve ~80% epoch-level accuracy vs. PSG gold standard — insufficient for clinical diagnosis but useful for population research and individual tracking.

**The validation challenge**: Most wearable algorithms are validated in controlled studies on healthy, young, predominantly white populations. Performance degrades for darker skin tones (PPG optical interference), older populations with more artifacts, and patients with chronic conditions that alter physiology. The FDA's 2021 Digital Health guidance and 2023 action plan specifically address this.
</div>

<div style="background-color: #8B0000; color: #FFFFFF; padding: 20px; border-radius: 8px; margin-bottom: 15px;">